Elevated matrix metalloproteinase-9 associated with stroke or cardiovascular death in patients with carotid stenosis

Nikolaj Eldrup1, Marie-Louise Moes Grønholdt, Henrik Sillesen

  • 1Department of Vascular Surgery, Rigshospitalet, Copenhagen University Hospital, Denmark.

Circulation
|October 13, 2006
PubMed

Insights

Elevated matrix metalloproteinase-9 levels in patients with carotid stenosis significantly increase the risk of stroke or cardiovascular death. Combining high matrix metalloproteinase-9 with echolucent plaques further amplifies this risk.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Biochemistry

Background:

  • Matrix metalloproteinase-9 (MMP-9) is implicated in atherosclerotic plaque destabilization.
  • Carotid stenosis poses a significant risk for cerebrovascular events.

Purpose of the Study:

  • To investigate the association between plasma MMP-9 levels and the risk of ipsilateral stroke or cardiovascular death in patients with carotid stenosis.
  • To evaluate the combined predictive value of MMP-9 and plaque characteristics on cardiovascular outcomes.

Main Methods:

  • Prospective follow-up of 207 patients with >= 50% carotid stenosis.
  • Measurement of plasma MMP-9 levels and assessment of carotid plaque echogenicity using B-mode ultrasound.
  • Analysis of cumulative incidence and hazard ratios for ipsilateral stroke or cardiovascular death.

Main Results:

  • Patients with MMP-9 levels above the median (41.9 ng/mL) had a 1.9-fold increased risk of ipsilateral stroke or cardiovascular death (P=0.002).
  • This association remained significant up to 10 years of follow-up.
  • Elevated MMP-9 combined with echolucent plaques showed a 4.4-fold increased risk for cardiovascular death and a 3.3-fold increased risk for stroke.

Conclusions:

  • Elevated plasma MMP-9 is a significant predictor of adverse cardiovascular events in patients with severe carotid stenosis.
  • The combination of high MMP-9 and echolucent plaque morphology substantially increases the risk of stroke and cardiovascular death.
Abstract